Decision

Astrazeneca Canada Inc. v. Apotex Inc., 2011 FCA 211 (Esomeprazole*)

Justice Sharlow; Justice Trudel; Justice Stratas - 2011-06-23

Read full decision. Automatically generated summary:

This is an appeal from an order dated April 29, 2011 of the Federal Court (per Justice Crampton), dismissing the appellants' motion for an interlocutory injunction.
The appellants sought to restrain the respondent and others from making, constructing, importing, exporting, using, selling to others to be used or offering to sell Apo-Esomeprazole and/or esomeprazole magnesium until the completion of a patent infringement trial.

Decision relates to:

 

Canadian Intellectual Property